Baxter (BAX) Tops Q4 EPS by 5c, Offers Q1 and FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/10/2026
- Wall St set to drop as tech declines, Middle East tensions mount
- Oil prices rise after Trump says Iran must pay price
- Oracle reports earnings today: Analysts say this metric could 'catalyze higher multiples'
- UBS sees generational semiconductor boom, highlights stock winners
- Has Tesla solved the self-driving puzzle? This analyst thinks so
- Hut 8 Mining Corp. (HUT) PT Raised to $55 at KBW As Management Delivers
- Micron to deliver 'another strong quarter', Goldman says
- UK's Ofcom requires tech firms to create crisis response plans
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Supermicro plans $7 billion financing to fund AI server orders
Baxter Reports 2018 Fourth-Quarter and Full-Year Results
January 31, 2019 7:15 AM ESTFourth-quarter revenue of $2.8 billion increased 2 percent on a reported basis and 5 percent on an operational basis Fourth-quarter GAAP earnings per share (EPS) of $0.66; adjusted EPS of $0.78 increased 22 percent Full-year revenue of $11.1 billion increased 5 percent on a reported basis and 3 percent on an operational basis Full-year GAAP earnings per share were $2.99; adjusted EPS of $3.05 increased 23 percent
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leading global medical products company, today reported results... More
